Vigil Neuroscience to Present in Upcoming June Investor Conferences
30 mai 2024 07h05 HE
|
Vigil Neuroscience, Inc.
WATERTOWN, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of...
Incident IQ Partners with Level Access to Enhance Digital Accessibility
30 mai 2024 07h02 HE
|
Incident IQ
Atlanta, GA, May 30, 2024 (GLOBE NEWSWIRE) -- Incident IQ, a leader in workflow management solutions for K-12 school districts, has partnered with Level Access, the leading digital accessibility...
Elevar Therapeutics Reports Landmark Median Overall Survival of 23.8 Months in First-Line Treatment for Unresectable Hepatocellular Carcinoma
30 mai 2024 07h00 HE
|
Elevar Therapeutics
Phase 3 CARES-310 study found combination of camrelizumab and rivoceranib continued to show sustained long-term survival compared with sorafenib as a first-line treatment for uHCCFinal analysis...
Omega Therapeutics To Participate In Two Upcoming Investor Conferences
30 mai 2024 07h00 HE
|
Omega Therapeutics
CAMBRIDGE, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of programmable...
BiomX to Present Phase 1b/2a Clinical Trial Data for BX004 at the 47th European Cystic Fibrosis Conference and at ASM Microbe 2024
30 mai 2024 07h00 HE
|
BiomX
GAITHERSBURG, Md. and NESS ZIONA, Israel, May 30, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and...
Reservoir Media Announces Fourth Quarter and Fiscal Year 2024 Results
30 mai 2024 07h00 HE
|
Reservoir Media, Inc.
Double-Digit Annual Revenue Growth in Both Segments, Surpassing Full Year Outlook Acquired Publishing & Recorded Rights of Legendary Artists and Emerging Talent Across Genres Fiscal 2025...
LSL Pharma Group Reports Record Revenues and Margins for the First Quarter 2024
30 mai 2024 07h00 HE
|
LSL Pharma Group Inc.
LSL Pharma Group Q1 results
Monte Rosa Therapeutics to Present at the Jefferies Global Healthcare Conference
30 mai 2024 07h00 HE
|
Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics to Present at the Jefferies Global Healthcare Conference
Zentalis Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
30 mai 2024 07h00 HE
|
ZENTALIS PHARMACEUTICALS
NEW YORK and SAN DIEGO, May 30, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically...
Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provides Business Update
30 mai 2024 07h00 HE
|
Roivant Sciences
BASEL, Switzerland and LONDON and NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today reported its financial results for the fourth quarter and fiscal year ended March 31, 2024,...